NCT04938804 Non-risk Based Lang Cancer Screening With a One-off LDCT
| NCT ID | NCT04938804 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Guangzhou Medical University |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 11,000 participants |
| Start Date | 2015-12-12 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 11,000 participants in total. It began in 2015-12-12 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021.The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC.
Eligibility Criteria
Inclusion Criteria: * Minimum age of 40 years among the residents in Guangzhou Exclusion Criteria: * Persons who had a diagnosis or treatment related to LC within the past 5 years, had undergone chest CT within the past year, or had significant cancer-related symptoms (e.g., hemoptysis, dyspnea, inability to climb two flights of stairs).
Contact & Investigator
Wenhua Liang, MD
PRINCIPAL INVESTIGATOR
The First Affiliated Hospital of Guangzhou Medical University
Frequently Asked Questions
Who can join the NCT04938804 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 74 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04938804 currently recruiting?
Yes, NCT04938804 is actively recruiting participants. Contact the research team at liangwh1987@163.com for enrollment information.
Where is the NCT04938804 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT04938804 clinical trial?
NCT04938804 is sponsored by The First Affiliated Hospital of Guangzhou Medical University. The principal investigator is Wenhua Liang, MD at The First Affiliated Hospital of Guangzhou Medical University. The trial plans to enroll 11,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.